Fine specificity of antibodies against phospholipids and beta-2-glycoprotein I in monoclonal gammopathy associated neuropathies

Journal of Neuroimmunology

Volumn 182, Issue 1-2, 2007, Pages 219-225

  Matà, Sabrina ^a   Grazia Giudizi, Maria ^b   Totaro, Maria ^b   Grippo, Antonello ^a,d   Fedi, Sandra ^c   Sorbi, Sandro ^a  

^a Department of Neurological and Psychiatric Sciences ^*  (Italy)

^b Department of Internal Medicine   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Anti phospholipid antibodies; Anti sulfatide antibodies; Dysimmune neuropathy; Monoclonal gammopathy

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CROSS REACTING ANTIBODY; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; SULFATIDE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CROSS REACTION; FEMALE; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE INJURY; NEUROIMMUNOLOGY; NEUROPATHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CROSS REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; PARAPROTEINEMIAS; POLYNEUROPATHIES; PROSPECTIVE STUDIES; SENSATION DISORDERS; SULFOGLYCOSPHINGOLIPIDS;

EID: 33845923177     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.10.016     Document Type: Article

References (32)

1. Asbury A.K., and Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27 (1990) S21-S24
2. Berger A.R., Bradley W.G., Brannagan T.H., Busis N.A., Cros D.P., Dalakas M.C., Danon M.J., Donofrio P., Engel W.K., England J.D., Feldman E.L., Freeman R.L., Kinsella L.J., Lacomis D., Latov N., Menkes D.L., Sander H.W., Thomas F.P., Triggs W.J., Windebank A.J., and Wolfe G.I. Neuropathy Association, Medical Advisory Committee, Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J. Peripher. Nerv. Syst. 8 (2003) 282-284
3. Brandt J.T., Barna L.K., and Triplett D.A. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Thromb. Haemost. 74 (1995) 1597-1603
4. Braun P.E., Frail D.E., and Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J. Neurochem. 39 (1982) 1261-1265
5. Carpo M., Meucci N., Allaria S., Marmiroli P., Monaco S., Toscano A., Simonetti S., Scarlato G., and Nobile-Orazio E. Anti-sulfatide IgM antibodies in peripheral neuropathy. J. Neurol. Sci. 176 (2000) 144-1450
6. Caudie C., Vial C., Petiot P., Bancel J., Lombard C., and Gonnaud P.M. Monoclonal IgM autoantibody activity vis-a-vis glycoconjugates of peripheral nerves: apropos of 112 cases. Ann. Biol. Clin. (Paris) 59 (2001) 567-577
7. Chapman J., Cohen-Armon M., Shoenfeld Y., and Korczyn A.D. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8 (1999) 127-133
8. England J.D., Gronseth G.S., Franklin G., Miller R.G., Asbury A.K., Carter G.T., Cohen J.A., Fisher M.A., Howard J.F., Kinsella L.J., Latov N., Lewis R.A., Low P.A., and Sumner A.J. American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation, Distal symmetrical polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64 (2005) 199-207
9. Farooqui A.A., Horrocks L.A., and Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106 (2000) 1-29
10. Freddo L., Hays A.P., Nickerson K.G., Spatz L., McGinnis S., Lieberson R., Vedeler C.A., Shy M.E., Autilio-Gambetti L., Grauss F.C., Petito F., Chess L., and Latov N. Monoclonal anti-DNA IgM kappa in neuropathy binds to myelin and to a conformational epitope formed by phosphatidic acid and gangliosides. J. Immunol. 137 (1986) 3821-3825
11. Fredman P., Lycke J., Andersen O., Vrethem M., Ernerudh J., and Svennerholm L. Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope. J. Neurol. 240 (1993) 381-387
12. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
13. Hughes G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br. Med. J. (Clin. Res. Ed.) 287 (1983) 1088-1089
14. Ilyas A.A., Quarles R.H., MacIntosh T.D., Dobersen M.J., Trapp B.D., Dalakas M.C., and Brady R.O. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 1225-1229
15. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36 (1997) 245-319
16. Kent M.N., Alvarez F.J., Ng A.K., and Rote N.S. Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain. Exp. Neurol. 163 (2000) 173-179
17. Leroy V., Arvieux J., Jacob M.C., Maynard-Muet M., Baud M., and Zarski J.P. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br. J. Haematol. 101 (1998) 468-474
18. Levine J.S., Koh J.S., Subang R., and Rauch J. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp. Mol. Pathol. 66 (1999) 82-98
19. Lopate G., Pestronk A., Kornberg A.J., Yue J., and Choksi R. IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve. J. Neurol. Sci. 151 (1997) 189-193
20. Mata S., Galli E., Amantini A., Pinto F., Sorbi S., and Lolli F. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome. Eur. J. Neurol. 13 (2006) 153-160
21. McNeil H.P., Simpson R.J., Chesterman C.N., and Krilis S.A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4120-4124
22. Merkel P.A., Chang Y., Pierangeli S.S., Harris E.N., and Polisson R.P. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. J. Rheumatol. 26 (1999) 591-596
23. Merten M., Motamedy S., Ramamurthy S., Arnett F.C., and Thiagarajan P. Sulfatides: targets for anti-phospholipid antibodies. Circulation 108 (2003) 2082-2087
24. Mizumoto H., Maihara T., Hiejima E., Shiota M., Hata A., Seto S., Atsumi T., Koike T., and Hata D. Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature. Eur. J. Pediatr. 165 (2006) 484-488
25. Norton W.T. Recent advances in myelin biochemistry. Ann. N.Y. Acad. Sci. 436 (1984) 5-10
26. Oosting J.D., Derksen R.H., Bobbink I.W., Hackeng T.M., Bouma B.N., and de Groot P.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood 81 (1993) 2618-2625
27. Press R., Mata S., Lolli F., Zhu J., Andersson T., and Link H. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J. Neurol. Sci. 190 (2001) 41-47
28. Robertson B., and Greaves M. Antiphospholipid syndrome: an evolving story. Blood Rev. 20 (2006) 201-212
29. Stern J.J., Ng R.H., Triplett D.A., and McIntyre J.A. Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undetermined significance. Am. J. Clin. Pathol. 101 (1994) 471-474
30. Suzuki M., Suetake K., Kasama T., Ariga T., Shiina M., and Kusunoki S. Characterization of a phospholipid antigen reacting with serum antibody in patients with peripheral neuropathies and paraproteinemia. J. Neurochem. 79 (2001) 970-975
31. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A., and Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42 (1999) 1309-1311
32. Yuhasz S.C., Senear D.F., Adamkiewicz J., Rajewsky M.F., Ts'o P.O., and Kan L.S. Thermodynamic investigation of monoclonal antibody alkylated nucleoside interaction as a model for epitope recognition on nucleic acids. Biochemistry 26 (1987) 2334-2342